🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa

Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa Ameerikaa Keessatti hirmaatuu

Qorannoo 37 Leukemia Biphenotypicii Hamaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 78 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03802695

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07094750

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Namoota walitti qabaa jiraSadarkaa 1/2
30 Days · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04065399

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT03683433

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Hanga umuriin 50 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT05322850

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Namoota walitti qabaa jiraSadarkaa 3
365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06177067

Personalized NK Cell Therapy in CBT

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 15 hanga 80 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT02727803

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Namoota walitti qabaa jiraSadarkaa 2
6 Months – 65 Years · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06013423

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Namoota walitti qabaa jiraSadarkaa 4
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT06289673

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443

Allo HSCT Using RIC and PTCy for Hematological Diseases

Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 75 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT05805605

Registry of Older Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT01137825

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT06551584

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT03670966

A Study of Revumenib and Mezigdomide in People With Leukemia

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT07356154

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
6 Months · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT04195633

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.